With a com­pet­i­tive Bill Si­bold tak­ing the helm at Sanofi Gen­zyme, long­time ex­ec David Meek­er makes an ex­it

When Sanofi stepped in close to six years ago and bought out Gen­zyme for $20 bil­lion, the phar­ma gi­ant pro­mot­ed David Meek­er to take the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.